Bismuth increases hydroxyl radical-scavenging activity of histamine H2-receptor antagonists

Pharmacological Reports

Volumn 58, Issue 2, 2006, Pages 215-220

  Kirkova, Margarita ^a   Alexandrova, Albena ^a   Yordanova, Neli ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

*OH radicals; Bismuth; Bismuth drug complexes; Histamine H2 receptor antagonists

Indexed keywords

ANTIULCER AGENT; ASCORBIC ACID; BISMUTH; BISMUTH CITRATE; CIMETIDINE; COPPER; DEOXYRIBOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; RANITIDINE; RANITIDINE BISMUTH CITRATE; ROXATIDINE;

ARTICLE; CONTROLLED STUDY; DEGRADATION KINETICS; DIGESTIVE SYSTEM ULCER; DRUG ACTIVITY; DRUG EFFICACY; FENTON REACTION; HELICOBACTER PYLORI; NONHUMAN; SCAVENGING SYSTEM;

EID: 33646780254     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Arvidsson S, Falt K, Marklund S, Haglund U: Role of free oxygen radicals in the development of gastrointestinal mucosal damage in Escherichia coli sepsis. Circ Shock, 1985, 16, 383-393.
2. Bardhan KD, Dekkers CPM, Lam SK, Nowak A, Demucekadell OBS: GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther, 1995, 9, 497-506.
3. Berstad A, Olafsson S, Tefera S, Berstad K, Hundal O, Bergseth M, Wilhelmsen I: Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a University hospital Norway. J Physiol Pharmacol, 1996, 47, 31-49.
4. Blaser MJ: Helicobacter pylori: its role in disease. Clin Infect Dis, 1992, 15, 386-391.
5. Butler J, Halliwell B: Reaction of iron-EDTA chelates with the superoxide radical. Arch Biochem Biophys, 1982, 218, 174-178.
6. Ching T-L, Haenen GRMM, Bast A: Cimetidine and other H2-receptor antagonists as powerful hydroxyl radical scavengers. Chem Biol Interact, 1993, 86, 119-127.
7. Dixon JS: Helicobacter pylori eradication: unraveling the facts. Scand J Gastroenter, 1995, 30, Suppl 211, 48-62.
8. Fraser AG, Levin JF, Pounder RE: Gastric persoption of bismuth from ranitidine bismuth citrate. Aliment Pharmacol Ther, 1995, 9, 447-450.
9. Gisbert JP, Gonzalez L, Calvet X: Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter, 2005, 10, 157-171.
10. Goldstein S, Meyerstein D, Czapski G: The Fenton reagents. Free Radic Biol Med, 1993, 15, 435-445.
11. Gotz JM, Veenendaal RA, Veselic N, Bernards S, Lamers CBHW: Triple therapy with ranitidine, clarithromycin and metronidazole in the treatment of Helicobacter pylori. Scand J Gastroenter, 1995, 30, Suppl 212, 34-37.
12. Graf E, Mahoney JR, Bryant RG, Eaton JW: Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J Biol Chem, 1984, 259, 3620-3624.
13. Greenaway FT, Brown LM, Dabrowiak JC, Thompson MR, Day VM: Copper(II)complexes of the antiulcer drug cimetidine. J Am Chem Soc, 1980, 102, 7782-7784.
14. Gutteridge JMC: Ferrous-salt-promoted damage to deoxyribose and benzoate. The increased effectiveness of hydroxyl radical scavengers in the presence of EDTA. Biochem J, 1987, 243, 709-714.
15. Gutteridge JMC: Reactivity of hydroxyl and hydroxyl-like radicals discriminated by release of thiobarbituric acid-reactive material from deoxy sugars, nucleotides and benzoate. Biochem J, 1984, 224, 761-767.
16. Gutteridge JMC, Wilkins S: Copper-dependent hydroxyl radical damage to ascorbic acid. Formation of a thiobarbituric acid-reactive product. FEBS Lett, 1982, 137, 327-330.
17. Gutteridge JM, Wilkins S: Copper salt-dependent hydroxyl radical formation. Damage to proteins acting as antioxidants. Biochim Biophys Acta, 1983, 759, 38-41.
18. Halliwell B: Superoxide-dependent formation of hydroxyl radicals in the presence of iron ions: its role in degradation on hyaluronic acid by a superoxidegenerating system. FEBS Lett, 1978, 96, 238-242.
19. Halliwell B, Grootveld M, Gutteridge J: Methods for the measurement of hydroxyl radicals in biochemical systems: deoxyribose and aromatic hydroxylation. Methods Biochem Anal, 1988, 33, 59-90.
20. Halliwell B, Gutteridge JMC: Formation of a thiobarbituric acid-reactive substance from deoxyribose in the presence of iron salts - the role of superoxide and hydroxyl radicals. FEBS Lett, 1981, 128, 347-351.
21. Halliwell B, Gutteridge JMC: Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys, 1986, 246, 501-514.
22. Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J, 1984, 219, 1-14.
23. Halliwell B, Gutteridge JMC, Aruoma OI: The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem, 1987, 165, 215-219.
24. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schuttze K, Taufer M, Wurzer H: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med, 1993, 328, 308-312.
25. Hudson N, Murrey FE, Codle AT, Turnbull GM, Lettis S, Hawkey CJ: Ranitidine bismuth citrate in the prevention of aspirin-induced gastric mucosal injury. Gut, 1992, 33, Suppl, S47.
26. Ishihara Y, Komuro Y, Ichikawa T, Hotta K: Effects of antiulcer drugs, NC-1300-o-3, FRG-8813 and Z-300 on ethanol-induced damage and gastric mucin content in rat stomach. Helv J Gastroenter, 1992, 5, Suppl 131, Abstr N 523.
27. Ivanov Ch, Petkov O, Petrov P, Taskov M, Athanassova R, Tsvetkova E, Kotsev V et al.: Synthesis, gastroprotective, antisecretory and anti-Helicobacter effect of (N-[3-(3-(1-piperidinylmethyl) phenoxy) propyl]-hydroxyacetamide -2-hydroxypropane-1,2,3-tricarboxylate-bismuth(3+) complex (MX1). J Pharm Pharmacol, 1996, 48, 297-301.
28. Jablonska, M: Healing of gastric body ulcer with gastroprotective versus antisecretory treatment. Dig Dis Sci, 1995, 40, 2016-2018.
29. 2-antagonist cimetidine with divalent and monovalent copper ions. Inorg Chem, 1986, 25, 2242-2246.
30. Kirkova M, Atanasova M, Russanov E: Effect of cimetidine and its metal complexes on nitroblue tetrazolium and ferricytochrome c reduction by superoxide radicals. Gen Pharmacol, 1999, 33, 271-276.
31. Labentz J, Borsch G Evidence to the essential role of Helicobacter pylori in gastric ulcer disease. Gut, 1994, 35, 19-22.
32. 2 receptor antagonists and Helicobacter pylori eradication. Scand J Gastroenter, 1995, 30, Suppl 212, 126-127.
33. Larsen A, Martiny N, Stoltenberg M, Danscher G, Rungby J: Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. Pharmacol Toxicol, 2003, 93, 82-90.
34. Laudanno OM, Bedini OA, Cesolari JA, San Miguel P: Evidence of anti-oxidant role of sucralfate in gastric mucosal protection. Ital J Gastroenter, 1990, 22, 19-21.
35. 1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats. J Pharm Pharmacol, 1997, 49, 791-795.
36. 1) against acetylsalicylic acid- and indomethacin-induced gastric mucosal damage in rats. Methods Find Exp Clin Pharmacol, 1998, 20, 667-672.
37. 2+. J Am Chem Soc, 1988, 110, 4293-4297.
38. Masci E, Colombo E, Testoni PA, Fanti L, Guslandi M, Tittobello A: Colloid bismuth versus famotidine in the treatment and prevention of duodenal ulcer relapse: results of a double-blind, double dummy randomized study. Fund Clin Pharmacol, 1995, 9, 280-283.
39. 4-induced liver cirrhosis. J Appl Toxicol, 1994, 14, 87-90.
40. Mesquita MA, Lorena SL, Almeida JR, Montes CG, Guerrazzi F, Campos LT, Zeitune JM: One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer. World J Gastroenterol, 2005, 11, 3566-3569.
41. Nosalova V, Petrikova M, Nosal R: Lipid peroxidation in normal and ulcerated gastric mucosa of rats treated with pentacaine and cimetidine. Agents Actions, 1989, 27, 160-162.
42. Ozawa T, Ueda Jun-ichi, Hanaki A: Copper(II)-albumin complex can activate hydrogen peroxide in the presence of biological reductants: first ESR evidence for the formation of hydroxyl radical. Biochem Mol Biol Int, 1993, 29, 247-253.
43. Peterson WL: Helicobacter pylori and peptic ulcer disease. N Engl J Med, 1991, 324, 1043-1047.
44. Rowley DA, Halliwell B: Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals in the presence of copper salts: a physiologically significant reaction? Arch Biochem Biophys, 1983, 225, 279-284.
45. Salim AS: Role of oxygen derived free radicals in mechanism of acute and chronic duodenal ulceration in the rat. Dig Dis Sci, 1990, 35, 73-79.
46. Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, McLaren A, Trvethick MA: Gastric anti-secretory mucosal protective anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther, 1993, 7, 23 7-246.
47. Taylor DN, Blaser MJ: The epidemology of Heliobacter infection. In: Helicobacter pylori in Peptic Ulceration and Gastritis. Ed. Marshall BJ, McCallum RW, Guerrant RL, Blackwell Scientific Publications, Boston, 1991, 127-139.
48. Tytgat GNG, Rauws EAJ: Campilobacter pylori and its role in peptic ulcer disease. Gastroenter Clin North Am, 1990, 19, 183-196.
49. Uchida K, Kawakishi S: Cimetidine anti-ulcer drug as a powerful hydroxyl radical scavenger. Agric Biol Chem, 1990, 54, 2485-2487.
50. Van Caekenberghe DL, Breyssens J: In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pylori. Antimicrob Agents Chemother, 1987, 31, 1429-1433.
51. Van der Vliet A, Bast A: Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med, 1992, 12, 499-513.
52. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. New Engl J Med, 1995, 333, 984-991.